<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02080676</url>
  </required_header>
  <id_info>
    <org_study_id>CMC-14-0001-CTIL</org_study_id>
    <nct_id>NCT02080676</nct_id>
  </id_info>
  <brief_title>Effects of Marihuana Use on Optic Nerve Parameters and Ocular Blood Flow</brief_title>
  <official_title>Effects of Marihuana Use on Optic Nerve Parameters and Ocular Blood Flow</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Carmel Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Carmel Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Purpose of study: to check the effect of medical cannabis given for approved medical
      indications on ocular parameters including intra ocular pressure, optic nerve fibers
      thickness and choroidal thickness.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Purpose of study: to check the effect of medical cannabis given for approved medical
      indications on ocular parameters including intra ocular pressure, Retinal Nerve Fiber Layer
      (RNFL) thickness, optic nerve fibers thickness and choroidal thickness.

      Adult patients with no ocular pathology that are being treated in the neurology or pain
      clinics with medical cannabis for different indications, were examined in the eye clinic.

      First examination took place after the patient was not smoking for 5 hours. Three more
      examinations took place 1 hour 3 hours and 5 hours after smoking cannabis.

      The following parameters were checked: blood pressure, pulse, visual acuity, intra ocular
      pressure, corneal thickness, axial length, slit lamp examination of anterior segment,
      fundoscopy and Optical Coherence Tomography (OCT) of the retina, and optic nerve.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>March 2014</start_date>
  <completion_date type="Anticipated">May 2016</completion_date>
  <primary_completion_date type="Anticipated">March 2016</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Intra ocular pressure</measure>
    <time_frame>5 hours</time_frame>
  </primary_outcome>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Intra Ocular Pressure</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Adult patients over the age of 18, with no ocular pathology that are being treated in the
        neurology or pain clinics with medical cannabis for different indications.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age over 18

          -  Treated with medical cannabis for approved medical indications

        Exclusion Criteria:

          -  Known ocular pathology

          -  Topical or systemic treatment for intra ocular pressure

          -  Previous topical, intra ocular or systemic steroid treatment
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Orna Geyer, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Carmel Medical Center</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Orna Geyer, MD</last_name>
    <phone>97248250926</phone>
    <email>orna_geyer@clalit.org.il</email>
  </overall_contact>
  <location>
    <facility>
      <name>Carmel Medical Center</name>
      <address>
        <city>Haifa</city>
        <country>Israel</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nurit Mathalone, MD</last_name>
      <phone>97248250477</phone>
      <email>Nurit.Mathalone@clalit.org.il</email>
    </contact>
    <investigator>
      <last_name>Orna Geyer, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <verification_date>October 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 5, 2014</study_first_submitted>
  <study_first_submitted_qc>March 5, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 6, 2014</study_first_posted>
  <last_update_submitted>October 13, 2015</last_update_submitted>
  <last_update_submitted_qc>October 13, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 14, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Carmel Medical Center</investigator_affiliation>
    <investigator_full_name>Orna Geyer</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>Cannabis</keyword>
  <keyword>Intra ocular pressure</keyword>
  <keyword>Ocular perfusion</keyword>
  <keyword>Blood pressure</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

